Pfizer/BioNTech announced the results of a clinical trial of 5 to 11-year-old children, the pharmaceutical company announced Friday. The news was released as the company has submitted information to the U.S. Food and Drug Administration (FDA). Pfizer/BioNTech is currently seeking emergency authorization to administer the coronavirus vaccine to children. Children participating in the clinical trial received a dose of 10 micrograms, an amount that was one-third of the adult dose. A total of 2,268 children from ages 5 to 11-years-old were included in the trial. Twice as many were given the child-level dose of the vaccine compared to others who received a placebo. Among those who received the placebo, 16 tested positive for COVID-19. Three cases were recorded among those who were administered the trial vaccine. Pfizer’s clinical trial in those 5 to 11 years old was not primarily designed to measure efficacy against the virus. Instead, it compared the …
RSS Feed | The Epoch Times